The Canadian Arthritis Patient Alliance (CAPA) submitted feedback on the draft implementation plan for the Renewal of the Canadian Task Force on Preventive Health Care to the Public Health Agency of Canada, reflecting the perspectives of people with lived experience,...
We participated in consultations held by the pan-Canadian Pharmaceutical Alliance (pCPA), an federal organization that determines whether or not it will enter into a negotiation for a drug and negotiates terms of an agreement with a drug manufacturer. We developed a...
Are you wondering what is health technology assessment (HTA)? CAPA provided input to Envision Pharma, a medical communications company, as they have developed the infographic on Health Technology Assessment. The purpose of this document is to provide a plain language...
We know there can be a lot of questions about the flu vaccine when you live with inflammatory arthritis. As people who live with arthritis, we put together some questions that our Medical Advisory Committee has answered for you here. FAQ (EN) FAQ...
CAPA’s Board member Emily Sirotich took part in the recent All-Virtual ACR Convergence 2020 Meeting on November 5-9, 2020, having submitted a number of abstracts and provided poster presentations as part of The COVID-19 Global Rheumatology Alliance (GRA) Patient...
English 
Français du Canada